Regenerative Medicine (journal)
 | |
| Discipline | Regenerative medicine |
|---|---|
| Language | English |
| Publication details | |
| History | 2006–present |
| Publisher | |
| Frequency | 8/year |
| 2.868 (2016) | |
| Standard abbreviations | |
| ISO 4 | Regen. Med. |
| Indexing | |
| CODEN | RMEECZ |
| ISSN | 1746-0751 (print) 1746-076X (web) |
| OCLC no. | 227191485 |
| Links | |
Regenerative Medicine is a peer-reviewed medical journal covering stem cell research and regenerative medicine. It was established in 2006 and is published by Future Medicine. The editor-in-chief is Chris Mason (University College London).
Regenerative Medicine has an online sister community site called RegMedNet. RegMedNet is a free-to-join website that publishes news on regenerative medicine and cell therapy research, policy and business, editorials from leaders in the field and free educational webinars.
Abstracting and indexing[edit]
The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, EMBASE/Excerpta Medica, EMCare, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.868, ranking it 15th out of 21 journals in the category "Cell & Tissue Engineering"[1] and 23rd out of 77 journals in the category "Engineering, Biomedical".[2]
References[edit]
- ^ "Journals Ranked by Impact: Cell & Tissue Engineering". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
- ^ "Journals Ranked by Impact: Engineering, Biomedical". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.